Loxo Oncology (two tropomyosin receptor kinase inhibitors) is Buildings and Property in United States that focus on United States business. They cover business area such as a portfolio, drug development right, Connecticut, United States, two tropomyosin receptor, kinase inhibitor, treatment, cancer.
-
United States
-
281 Tresser Boulevard
9th Floor
Stamford, CT 06901
United States
Private
a portfoliodrug development rightConnecticutUnited Statestwo tropomyosin receptorkinase inhibitortreatmentcancer
* We use standard office opening hours in near Loxo Oncology (two tropomyosin receptor kinase inhibitors)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Loxo Oncology (two Tropomyosin Receptor Kinase Inhibitors) is Buildings and Property business from United States that founded in - ( years old in ), Loxo Oncology (two tropomyosin receptor kinase inhibitors) business is focusing on United States.
Loxo Oncology (two tropomyosin receptor kinase inhibitors) headquarter office and corporate office address is located in 281 Tresser Boulevard 9th Floor Stamford, CT 06901 United States.
Loxo Oncology (two tropomyosin receptor kinase inhibitors) was founded in United States.
In , Loxo Oncology (two tropomyosin receptor kinase inhibitors) is currently focus on United States sector.
Above is snippet of Google Trends for "United States" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Loxo Oncology (two tropomyosin receptor kinase inhibitors), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
